Trial Profile
Multicenter, prospective, and non-randomized investigation on efficacy and safety of a newly designed treatment protocol for newly diagnosed acute promyelocytic leukemia patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Arsenic trioxide (Primary) ; Tretinoin (Primary) ; Cytarabine; Daunorubicin; Mitoxantrone
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- 24 Feb 2016 Status changed from not yet recruiting to completed.
- 19 Aug 2013 New trial record